Human albumin is effective in prevention of severe OHSS

Acta Obstetricia et Gynecologica Scandinavica

Volumn 80, Issue 10, 2001, Pages 878-

  Al Inany, H G ^a  

^a NONE   (Egypt)

Author keywords

Intervenous albumin; Ovarian hyperstimulation syndrome; Ovulation induction; Volume loading

Indexed keywords

CHORIONIC GONADOTROPIN; HUMAN ALBUMIN; VASCULOTROPIN;

CLINICAL TRIAL; CORPUS LUTEUM; DRUG EFFICACY; EMBRYO TRANSFER; FERTILIZATION IN VITRO; HUMAN; OSMOTIC PRESSURE; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT;

EID: 0034771115     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2001.801002.x     Document Type: Review

References (28)

1. High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by 'prolonged coasting' of very hyperstimulated patients: A multicentre study
2. Ovarian hyperstimulation syndrome: A current survey
3. Thromboembolic disease associated with ovarian and assisted conception techniques
4. Ovarian hyperstimulation syndrome after superovulation for IVF and related procedures
5. Plasma estradiol is superior to ultrasound and urinary estriol glucuronide as a predictor of ovarian hyperstimulation during induction of ovulation with menotropins
6. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome
7. The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome
8. Intravenous albumin prevents moderate-severe ovarian hyperstimulation in in vitro fertilisation patients: A prospective randomized and controlled study
9. Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome
10. Intravenous albumin combined with low dose human chorionic gonadotrophin and late step-down administration of menotropins are effective in prevention of severe ovarian hyperstimulation syndrome in high-risk patients in an in vitro fertilization program
11. Colloid volume expanders: Problems, pitfalls, and possibilities
12. Pharmacology of colloids and crystalloids
13. Association of serum albumin and mortality risk
14. Albumin. Background and use
15. Human albumin solutions
16. Unique features of albumin: A brief review
17. Decreased incidence of severe ovarian hyperstimulation syndrome in high risk in vitro fertilisation patients receiving intravenous albumin: A prospective study
18. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration
19. Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilisation program: A prospective, randomised, placebo-controlled study
20. Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome
21. Comparison of intravenous albumin and transfer of fresh embryos with cryopreservation of all embryos for subsequent transfer in prevention of ovarian hyperstimulation syndrome
22. The role of intravenous albumin in the prevention of severe ovarian hyperstimulation syndrome. A pilot experimental study
23. Severe ovarian hyperstimulation syndrome: Is it really preventable by prophylactic intravenous albumin?
24. Does intravenous administration of human albumin prevent severe ovarian hyperstimulation syndrome?
25. Albumin in the prevention of severe OHSS
26. Human albumin administration in critically ill patients: Systematic review of randomised controlled trials
27. Prophylactic intravenous hydroxyethyle starch solution prevents moderate-severe ovarian hyperstimulation in in-vitro fertilization patients: A prospective, randomized, double-blind and placebo-controlled study
28. Reduced incidence of ovarian hyperstimulation syndrome by prophylactic infusion of hydroxyethyl starch solution in an in-vitro fertilization programme